<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">284868</id>
  <title nil="true"/>
  <common-name>2-[(e)-1-(1-methyl-2,4,6-trioxo-5-prop-2-enyl-1,3-diazinan-5-yl)propan-2-ylideneamino]-1-nitroguanidine</common-name>
  <description>2-[(e)-1-(1-methyl-2,4,6-trioxo-5-prop-2-enyl-1,3-diazinan-5-yl)propan-2-ylideneamino]-1-nitroguanidine belongs to the pyrimidines and pyrimidine derivatives, a subclass of diazines within the organic compounds. This organoheterocyclic compound has the formula C12H17N7O5 and an average molecular weight of 339.31 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>129626835</pubchem-id>
  <chemical-formula>C12H17N7O5</chemical-formula>
  <weight>339.31</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-27T20:30:28Z</created-at>
  <updated-at type="dateTime">2026-08-27T20:30:28Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(=NN=C(N)N[N+](=O)[O-])CC1(C(=O)NC(=O)N(C1=O)C)CC=C</moldb-smiles>
  <moldb-formula>C12H17N7O5</moldb-formula>
  <moldb-inchi>InChI=1S/C12H17N7O5/c1-4-5-12(8(20)14-11(22)18(3)9(12)21)6-7(2)15-16-10(13)17-19(23)24/h4H,1,5-6H2,2-3H3,(H3,13,16,17)(H,14,20,22)/b15-7+</moldb-inchi>
  <moldb-inchikey>ZDTXNJDANPFCKW-VIZOYTHASA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">339.1291167</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-0.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM280761</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[(e)-1-(1-methyl-2,4,6-trioxo-5-prop-2-enyl-1,3-diazinan-5-yl)propan-2-ylideneamino]-1-nitroguanidine</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazines</klass>
  <subklass>Pyrimidines and pyrimidine derivatives</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0236714</sync-id>
  <structure-inchikey>ZDTXNJDANPFCKW-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>800000000000000800200000000000001000880000010000000000000020040000000000000000000000002000000000000000000000000000000000000000000000000004000020000000004200005004000100400000100000010000000200000000000000044000000108000000000c10000000400000000048000000000800200000004080001000000000000000000000000800000000000800000000001200080000000000000000810000000000000000000000000000000000000000000000040000000000000000000000000000000000000000020000000080000000000000000000000000001000001000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAYAAAAGAAAAIABBgBgAAAAAQMGACgAAAAD
BAcAKAAAAAMDBwAoAAAAAwMGACgAAAADBAcAaAAAAAMBAgcAaAAAAAMCAQcg
KgAAAAEDBAgAKAAAAAMCCCAqAAAA/wMBBgBgAAAAAgIGACAAAAAEBgAoAAAA
AwQIACgAAAADAgcAaAAAAAMCAQYAKAAAAAMECAAoAAAAAwIHACgAAAADAwYA
KAAAAAMECAAoAAAAAwIGAGAAAAABAwYAYAAAAAICBgBoAAAAAwMBBgBoAAAA
AwICCwABAAECKAICAyADBCgCBAUgBAYgBgcgBwgoAgcJIAEKAAoLAAsMAAwN
KAIMDiAODyAPECgCDxEgERIgEhMoAhEUAAsVABUWABYXCAISCwBCAQAAAAYL
EhEPDgwXBAAAAAAAAAAW
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:59:00Z</structure-indexed-at>
</compound>
